Dismantling the Obesity Paradox in Acute Pulmonary Embolism

K. Ho (New York, United States of America), S. Nasserifar (New York, United States of America), P. Kohli (New York, United States of America), J. Poon (New York, United States of America), Y. Herrera (New York, United States of America), A. Pattupara (New York, United States of America), A. Sotelo (New Jersey, United States of America), R. Jean (New York, United States of America)

Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Session: Epidemiology, diagnosis and management of pulmonary embolism
Session type: E-poster session
Number: 3575

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Ho (New York, United States of America), S. Nasserifar (New York, United States of America), P. Kohli (New York, United States of America), J. Poon (New York, United States of America), Y. Herrera (New York, United States of America), A. Pattupara (New York, United States of America), A. Sotelo (New Jersey, United States of America), R. Jean (New York, United States of America). Dismantling the Obesity Paradox in Acute Pulmonary Embolism. 3575

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


Pulmonary Embolism
Source: Breathe, 15 (4) 360; 10.1183/20734735.ELF154
Year: 2019



Pulmonary Hypertension in Childhood
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020


Isolated hypocapnia: A sign not to be neglected
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Comparison of Septic and Non-Septic Pulmonary Embolism in Children
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019


Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Clinical and Epidemiological Features of Lung Cancer Complicated with Pulmonary Embolism
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017


Is there an Optimal Door-to-Treatment Time for Acute Pulmonary Embolism? A National Propensity Match Analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020


Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 2014
Year: 2014

Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


Leptospirosis: An Unlikely Cause of Pulmonary Haemorrhage?
Source: International Congress 2019 – Pulmonary vascular diseases?
Year: 2019